The present invention encompasses compounds of the formula (I)
wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
The present invention encompasses compounds of the formula (I)
wherein the groups A, Cy, X1 and Y are defined herein, which are suitable for the treatment of diseases related to BTK, process of making, pharmaceutical preparations which contain compounds and their methods of use.
本发明包括式 (I) 的化合物
其中基团 A、Cy、X1 和 Y 在本文中定义,适用于治疗与 BTK 有关的疾病、制造工艺、含有化合物的药物制剂及其使用方法。
Fungicide N-Cyclopropyl-Sulfonylamide Derivatives
申请人:Schwarz Hans-Georg
公开号:US20090137611A1
公开(公告)日:2009-05-28
The present invention relates to N-cyclopropyl-sulfonylamide derivatives of formula (I) wherein the substituents are cyclic groups, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions: (I)
Inhibitors of Cyclin Kinase Inhibitor p21
申请人:Weiss Robert
公开号:US20110301192A1
公开(公告)日:2011-12-08
The present invention provides compounds that inhibit cyclin kinase inhibitor p21, such as compounds of formula I. The present invention also provides compositions including compounds of Formula I and a pharmaceutically acceptable excipient. In addition, the present invention provides methods of inhibiting cyclin kinase inhibitor p21 and of treating cancer.
POLYIMIDE POLYMER SOLUTION, POLYIMIDE POLYMER, TRANSPARENT FILM, DISPLAYING DEVICE AND SOLAR CELL
申请人:Leu Chyi-Ming
公开号:US20120160317A1
公开(公告)日:2012-06-28
A polyimide polymer solution, a polyimide polymer, a transparent film, a display device and a solar cell are provided. The polyimide polymer has at least one of a repeating unit of formula (D) and a repeating unit of formula (J) and at least one of a repeating unit of formula (Q) and a repeating unit of formula (T).
One of B and B′ is cyclo-aliphatic compound, and the other is aromatic compound, a molar mass ratio of the cyclo-aliphatic compound to the aromatic compound is
1˜4
, A and A′ are identical or different aromatic diamines, and at least one of A and A′ is aromatic diamine with ether groups, and A could be the same as or different from A′.